Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The Nevanac product information insert says that it can cause increase in eye pressure in 5-10% of patients. There is very little published literature on the effect of topical Nepafenac eye drops on eye pressure in normal people. The purpose of our study is to report this effect with a working hypothesis that there is no increase in eye pressure following use of Nepafenac eye drops.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| nepafenac | Experimental | Nepafenac 0.1% eye drops, 3 times a day |
|
| control | No Intervention | No intervention in the control arm |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| nepafenac | Drug |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| Intraocular pressure | Intraocular pressure elevation of more than 4 mmHg from baseline | 4 weeks |
| Intraocular pressure | Intraocular pressure elevation of more than 4 mmHg from baseline | 8 weeks |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Paaraj R Dave, MD | TV Patel Eye Institute | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Dr TV Patel Eye Insititute | Vadodara | Gujarat | 390001 | India |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 10850857 | Background | Gamache DA, Graff G, Brady MT, Spellman JM, Yanni JM. Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy. Inflammation. 2000 Aug;24(4):357-70. doi: 10.1023/a:1007049015148. | |
| 16488953 | Result | Chiba T, Kashiwagi K, Chiba N, Tsukahara S. Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension. Br J Ophthalmol. 2006 Mar;90(3):314-7. doi: 10.1136/bjo.2005.080895. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| C414203 | nepafenac |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 18664937 | Result | Warren KA, Fox JE. Topical nepafenac as an alternate treatment for cystoid macular edema in steroid responsive patients. Retina. 2008 Nov-Dec;28(10):1427-34. doi: 10.1097/IAE.0b013e31817e7ead. |